alprazolam has been researched along with bromazepam in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Abdelkafi, H; Ait Ouarab, L; Barbier, J; Buisson, DA; Caramelle, L; Cintrat, JC; Clerget, A; Gillet, D; Michau, A; Montoir, D; Ngadjeua, F; Pons, V | 1 |
| Bourin, M; Bradwejn, J; Colombel, MC; Hascoet, M; Mansouri, B | 1 |
| Bruun-Hansen, J; Sonne, LM | 1 |
| Annable, L; Chouinard, G; Fontaine, R; Labonte, A | 1 |
| Ator, NA; Brady, JV; Griffiths, RR; Lamb, RJ; Lukas, SE | 1 |
| Drobizhev, MIu; Drozdov, DV; Smulevich, AB; Syrkin, AL | 1 |
| Gehde, E; Heinze, HJ; Johannes, S; Münte, TF; Seewald, M | 1 |
| Berry, RA; Boezaart, AP; Laubscher, JJ; Nell, ML | 1 |
| Adnet, P; Boittiaux, P; Forget, AP; Loeb, P; Mille, FX | 1 |
| Busto, UE; Gomez-Mancilla, B; Greenblatt, DJ; Kaplan, HL; Sellers, EM; Wright, CE; Zawertailo, L | 1 |
| Barthelmé, B; Poirot, Y | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Abrahamowicz, M; Čapek, R; Sylvestre, MP; Tamblyn, R | 1 |
| Holm, KM; Johansen, SS; Linnet, K; Skov, L | 1 |
| Bokehi, JR; Bokehi, LC; Castilho, SR; Gomes, MDSA; Oliveira, EB; Ramos, TB | 1 |
| Batalha, V; Bonifácio, MJ; Braksator, E; Fernandes, H; Hebeisen, S; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
2 review(s) available for alprazolam and bromazepam
| Article | Year |
|---|---|
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
Postmortem Brain and Blood Reference Concentrations of Alprazolam, Bromazepam, Chlordiazepoxide, Diazepam, and their Metabolites and a Review of the Literature.
Topics: Alprazolam; Blood-Brain Barrier; Bromazepam; Chlordiazepoxide; Diazepam; Forensic Toxicology; Humans | 2016 |
5 trial(s) available for alprazolam and bromazepam
| Article | Year |
|---|---|
[Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1986 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; Clinical Trials as Topic; Clonazepam; Diazepam; Humans; Panic; Receptors, Cell Surface; Receptors, GABA-A; Recurrence; Substance Withdrawal Syndrome | 1983 |
Effects of alprazolam and bromazepam on visual search and verbal recognition memory in humans: a study with event-related brain potentials.
Topics: Adult; Alprazolam; Bromazepam; Evoked Potentials; Humans; Male; Memory; Visual Pathways | 1996 |
Evaluation of anxiolysis and pain associated with combined peri- and retrobulbar eye block for cataract surgery.
Topics: Aged; Alprazolam; Anesthesia, Local; Anesthetics, Local; Anti-Anxiety Agents; Anxiety; Bromazepam; Bupivacaine; Cataract Extraction; Catheterization, Peripheral; Diazepam; Double-Blind Method; Eye; Humans; Injections; Lidocaine; Pain; Patient Satisfaction; Placebos; Preanesthetic Medication | 1998 |
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Topics: Adult; Affect; Alprazolam; Anti-Anxiety Agents; Bromazepam; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Logistic Models; Lorazepam; Male; Middle Aged; Psychomotor Performance | 2000 |
18 other study(ies) available for alprazolam and bromazepam
| Article | Year |
|---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Topics: Benzodiazepinones; Golgi Apparatus; HeLa Cells; Humans; Protein Transport; Shiga Toxins; Structure-Activity Relationship | 2020 |
Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
Topics: Alprazolam; Animals; Anxiety; Behavior, Animal; Benzodiazepines; Bromazepam; Dose-Response Relationship, Drug; Drug Tolerance; Electroshock; Lorazepam; Male; Mice; Motor Activity; Muscle Relaxation; Placebos; Sleep | 1992 |
Three more benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Bromazepam; Flunitrazepam; Humans; Sleep Initiation and Maintenance Disorders | 1983 |
Benzodiazepines: drug discrimination and physiological dependence.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Humans; Lorazepam; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1984 |
[Alprazolam and bromazepam in the treatment of the mental disorders in patients with cardiovascular diseases].
Topics: Alprazolam; Bromazepam; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Drug Tolerance; Female; Humans; Male; Mental Disorders; Middle Aged; Time Factors | 1994 |
[Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].
Topics: Abdomen, Acute; Adult; Alprazolam; Anti-Anxiety Agents; Bromazepam; Diagnosis, Differential; Headache; Humans; Hydroxyzine; Male; Midazolam; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Truth Disclosure; Vomiting | 1997 |
[Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Cardiovascular Diseases; Chronic Disease; Depression; Drug Prescriptions; Female; Follow-Up Studies; France; General Adaptation Syndrome; Humans; Male; Mental Disorders; Middle Aged; Phobic Disorders; Psychometrics; Risk Factors; Substance-Related Disorders | 2008 |
Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
Topics: Accidental Falls; Aged; Alprazolam; Benzodiazepines; Bromazepam; Chlordiazepoxide; Clonazepam; Female; Flurazepam; Humans; Lorazepam; Male; Proportional Hazards Models; Risk Factors; Temazepam | 2012 |
Information about benzodiazepines: what does the internet offer us?
Topics: Alprazolam; Benzodiazepines; Brazil; Bromazepam; Humans; Internet | 2020 |
Voltage-clamp evidence of GABA
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Receptors, GABA-A; Zolpidem | 2022 |